Treatment effectiveness of two Chinese herbal medicine formulae in upper respiratory tract infections-a randomized double-blind placebo-controlled trial

Family Practice

Volumn 29, Issue 6, 2012, Pages 643-652

  Wong, Wendy ^a   Lam, Cindy Lo Kuen ^a   Fong, Daniel Yee Tak ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chinese medicine; Family medicine; Infectious diseases; Multidisciplinary care; Randomized controlled trial; Respiratory medicine

Indexed keywords

HERBACEOUS AGENT; JING FANG BAI DU SAN; PLACEBO; UNCLASSIFIED DRUG; YING QIAO SAN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFECT; FEMALE; HERBAL MEDICINE; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; WIND COLD SYNDROME; WIND HEAT SYNDROME;

ADOLESCENT; ADULT; AGED; DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; FEMALE; HONG KONG; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; QUESTIONNAIRES; RESPIRATORY TRACT INFECTIONS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84869998348     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cms027     Document Type: Article

References (38)

1. Marshall I. Zinc for the common cold. The Cochrane Database of Systematic Reviews 1999, issue 2.
2. Scott J, Orzano AJ. Evaluation and treatment of the patient with acute undifferentiated respiratory tract infection. J Fam Pract 2001; 50: 1070-77.
3. National Institute of Health.Acupuncture. NIHConsensus Statement Online 1997 November 3-5. Vol. 15, pp. 1-34. Bethesda, Maryland. http://consensus.nih.gov/1997/1997Acupuncture107html.htm.
4. Ernst E. Complementary medicine-doing more good than harm? Br J Gen Pract 1996; 46: 60-1.
5. Tang JL, Zhan S-Y, Ernst E. Review of randomized controlled trials of traditional Chinese medicine. BMJ 1999; 319: 160-1.
6. Leung PC, Wong MWN. A critical analysis of professional and academic publications on traditional Chinese medicine in China. Am J Chin Med 2001; 30: 177-81.
7. Wong S. Evaluation of general outpatient clinics using the primary care assessment tools. In: Health Research Symposium 2010, September 11 2010, Hong Kong, 2010, p. 19.
8. Wu T, Zhang J, Qiu Y, Xie L, Liu G. Chinese medicinal herbs for the common cold. Cochrane Database of Systematic Review 2007; 24: issue 1. Art. No.: CD004782.
9. Kaptchuk TJ. The double-blind, randomized, placebo-controlled trial: gold standard or golden calf? J Clin Epidemiol 2001; 54: 541-9.
10. Fitter MJ, Thomas KJ. Evaluating complementary therapies for use in the National Health Service: 'horses for courses'. Part 1: the design challenge. Complement Ther Med 1997; 5: 90-3.
11. Zaslawski C. Clinical reasoning in traditional Chinese medicine: implications for clinical research. Clin Acupunct Orient Med 2003; 4: 94-101.
12. Bensoussan A, Talley NJ, Hing M et al. Treatment of irritable bowel syndrome with Chinese herbal medicine. JAMA 1998; 280: 1585-9.
13. Medical Research Council. A Framework for Development and Evaluation of RCTs for Complex Interventions to Improve Health. 2000. http://www.mrc.ac.uk/pdf-mrc_cpr.pdf (accessed on 8 August 2005).
14. Levin JS, Glass TA, Kushi LH et al. Quantitative methods in research on complementary and alternative medicine: a methodological manifesto. Med Care 1997; 35: 1079-94.
15. WHO. General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine. Rockville, MD: World Health Organization. 2000, 1-74. http://dravyagunatvpm.files. wordpress.com/2009/01/health-research-guide.pdf.
16. Critchley JAJH, Zhang Y, Suthisisang CC, Chan TYK, Tomlinson B. Alternative therapies and medical science: designing clinical trials of alternative/complementary medicines-is evidencebased traditional Chinese medicine attainable? J Clin Pharmacol 2000; 40: 462-7.
17. Tonelli MR, Callahan TC. Why alternative medicine cannot be evidence-based. Acad Med 2001; 76: 1213-20.
18. Lee A, Chan KK, Tsan WY et al. A morbidity survey in Hong Kong, 1994. Hong Kong pract 1994; 17: 246-55.
19. WHO. Immunizations, Vaccines and Biologicals. 2003. http://www.who.int/immunization/topics/influenza/en/index.html (accessed on 25 February 2012).
20. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997; 278: 901-4.
21. Release P. CUHK Study Indicates HK Suffers Huge Economic Losses Due to Flu and Flu-like Illnesses. 2002. http:// www.cuhk.hk/ipro/020131e.htm. (accessed on 25 February 2012).
22. Zhang R, Mao S, Shao Q et al. An investigation of Chinese medicine diagnosis pattern (III). J Beijing Univ Tradit Chin Med 1999; 22: 49-52.
23. Jun L. The investigation of 109 cases on the formula of respiratory infections. J Emerg Syndr Chin Med 1995; 4: 275-6.
24. Department of Health Chinese Medicine Division. Common Methods on Prevention and Treatment of Influenza with Chinese Medicine. Department of Health, HKSAR Government, Chinese Medicine Division, 2005. http:// www.cmchk.org.hk/cmp/news/CA4DUZWT..pdf.
25. State Administration of Traditional ChineseMedicine of the People Republic of China. Treatment Guideline of H1N1 Influenza by Chinese Medicine (2009 draft). Mainland China.
26. Taylor JA, Weber W, Standish L et al. Efficacy and safety of echinacea in treating upper respiratory tract infections in children. JAMA 2003; 290: 2824-30.
27. Zhang W, Jiang H, ZhouWet al. Chinese medicine for acute upper respiratory tract infection: a systematic review of randomized controlled trials. J Chin Integr Med 2009; 7: 706-16.
28. Leung P. Evidence-based alternative medicine. Hong Kong Med J 2001; 7: 333-4.
29. Yu MY. Observational study on the treatment of air-conditioner syndrome by Jing Fang Bai Du San. Liaoning J Tradit Chin Med 1999; 26: 358-9.
30. Tam MQ. Clinical observation of Jing Fang Bai Du san on the treatment of Xu Han type common cold. J Guangdong Med Coll 2003; 21: 63-4.
31. Lam CLK, Gandek B, Ren XS, Chan MS. Test of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36 Health Survey. J Clin Epidemiol 1998; 51: 1139-47.
32. Zhao L, Leung KF, Chan K. The Chinese quality of life instrument: reliability and validity of the Hong Kong Chinese version (ChQOL-HK). Hong Kong Practit 2007; 29: 220-32.
33. Ying LR. An observational study on the The combination effects of Jing Fang Bai Du san on anti-bacteria action. Med J Guizhou 1996; 20: 76-7.
34. Pan J, Liu H, Han C et al. Pharmacological studies of Yinqiaosan concentrated Tea Bag on anti-inflammation defervescence acesodyne bacteriostasis and antivirus. GuangZhou Inst Tradit Chin Med Materia Medica 2003; 13: 43-7.
35. Lui MW. 62 studies on treatment of acute upper respiratory tract infections by Ying Qiao san. J Med Coll 2001; 26: 435-6.
36. WHO. WHO Traditional Medicine Strategy, 2002-2005, World Health Organization, 2002. http://apps.who.int/medicinedocs/ en/d/Js2297e/3.1.html
37. Zhang Y, Chang J, Zhang R et al. Mahuang Zhisou Capsule in treatment of acute upper respiratory tract infection of external wind-cold syndrome: a multi-center, randomized controlled, and double-blind trial. J Chin Integr Med 2008; 6: 581-5.
38. Zhang L, Guo Q, Li H. Observational study of the integrative medicine treatment of acute respiratory tract infections. J Emergency Traditional Chinese Med 2008; 17: 155-6.